Spondyloarthritides undergoing a renaissance, but challenges exist

Rheumatologists’ understanding of the spectrum of spondyloarthritis is undergoing an evolution that has revealed an underrecognition of the disease, particularly in women, but regulatory recognition of the spectrum of disease in the United States has...

Consider phototherapy for certain psoriasis patients

LAS VEGAS – Psoriasis patients who are unresponsive to topical therapy, do not have psoriatic arthritis, and can make regular office visits may be candidates for successful treatment with phototherapy. A patient with type II...

Psoriasis patients’ QOL improved with calcipotriene/betamethasone

LAS VEGAS – Adults with localized psoriasis reported significant improvement in quality of life after 2 and 8 weeks of treatment with a combination topical suspension, based on data from 147 adults. Calcipotriene 0.005% plus...

Severe diaper rash, cradle cap raise suspicion for pediatric psoriasis

NEWPORT BEACH, CALIF. – A history of severe cradle cap and diaper dermatitis helps to differentiate between pediatric psoriasis and atopic dermatitis, so be sure to ask, according to Dr. Alan Menter, chief of the...

VIDEO: New diagnostic criteria catch systemic lupus earlier

Minimal disease activity in psoriatic arthritis is a realistic target

LAS VEGAS – A number of drugs are showing promise for the treatment of psoriatic arthritis, but broader improvements are needed with respect to treatment strategies, according to Dr. Iain McInnes. Earlier diagnosis, appropriate therapies,...

Topical treatments for psoriasis: Molecules to watch

Though it’s been more than a decade since a new class of topical medication has been approved for psoriasis, there are several promising new anti-inflammatory compounds to keep an eye on, says Dr. Linda Stein...

Options exist for psoriasis patients with multiple anti-TNF failures

LAS VEGAS – The use of an alternative anti–tumor necrosis factor drug is not necessarily precluded in a psoriasis patient with both skin and joint symptoms who has failed two previous anti-TNF drugs, according to...

Treatment options expand for pulmonary arterial hypertension in scleroderma

LAS VEGAS – Scleroderma patients are at particularly high risk for developing pulmonary arterial hypertension, but treatment options are expanding, and with early referral to a PAH specialist, outcomes can be improved, according to Dr. Ronald...

Most data reassure regarding TNF inhibitors and cancer

LAS VEGAS – Concerns about use of a tumor necrosis factor inhibitor in a rheumatoid arthritis patient with a history of cancer are common, but the data are largely reassuring, according to Dr. Iain McInnes...

Pages